Systemic lysis protects against the effects of platelet activation during coronary thrombolysis.
Systemic lysis may protect against the platelet activation and ongoing thrombosis associated with coronary thrombolysis. To address this hypothesis, we compared urokinase and tissue-type plasminogen activator (t-PA) given intravenously in a chronic, canine model of coronary thrombosis. T-PA 10 micro...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1991
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295678/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1939647/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115471 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|